Oral forodesine (Bcx-1777) is clinically active in refractory cutaneous T-cell lymphoma: Results of a phase I/II study.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Duvic, M; Forero-Torres, A; Foss, F; Olsen, EA; Kim, Y

Published Date

  • November 16, 2006

Published In

Volume / Issue

  • 108 / 11

Start / End Page

  • 698A - 698A

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Language

  • English

Conference Location

  • Orlando, FL